Research brief

Melatonin vs N-Acetyl-5-Methoxytryptamine — The Same Thing

Q: Can I use N-acetyl-5-methoxytryptamine in the same protocols designed for melatonin?

Yes — all dosing, solubility, and assay protocols written for melatonin apply directly to material labeled N-acetyl-5-methoxytryptamine because they describe the same compound. Solubility in DMSO (50 mg/mL), ethanol (25 mg/mL), and reconstitution volumes for target concentrations are identical. The only protocol adjustment required is administrative: update your standard operating procedures to list both names as synonyms so procurement and quality assurance staff recognise the compounds as equivalent.

Q: Why does my supplier’s mass spec report list N-acetyl-5-methoxytryptamine if I ordered melatonin?

Mass spectrometry identifies compounds by molecular structure, not trade names — the software matches fragment ion patterns against reference libraries indexed by IUPAC nomenclature. When the instrument detects molecular ions at m/z 233, 174, and 159 with retention time matching reference standard 73-31-4, it reports the compound as N-acetyl-5-methoxytryptamine because that’s the systematic identifier in the NIST MS library. This is confirmation you received melatonin, verified through objective spectroscopic analysis rather than label claims.

Q: Is N-acetyl-5-methoxytryptamine more expensive than melatonin?

Pricing depends on purity grade, batch size, and supplier rather than nomenclature — research-grade melatonin and N-acetyl-5-methoxytryptamine from the same vendor at the same purity (e.g., 99% by HPLC) cost identically because they are the same compound. Pricing differences between suppliers reflect synthesis scale, COA documentation depth, and customer service rather than molecular differences. Institutional procurement systems sometimes flag systematic names as ‘specialty chemicals’ with inflated pricing — that’s an administrative error, not a market reality.

Q: What happens if I mix up melatonin and N-acetyl-5-methoxytryptamine in my lab inventory?

Nothing — because they are the same molecule, mixing vials labeled with different names creates no experimental risk as long as concentration and purity are equivalent. The risk is administrative: mislabeling can cause inventory tracking errors or duplicate orders. Best practice is to relabel all melatonin inventory with both common and systematic names (e.g., ‘Melatonin (N-acetyl-5-methoxytryptamine), CAS 73-31-4’) to prevent confusion and satisfy both purchasing departments and lab staff familiar with either term.

Q: Do clinical studies use melatonin or N-acetyl-5-methoxytryptamine?

Clinical literature overwhelmingly uses ‘melatonin’ in study titles, abstracts, and patient-facing documentation because it’s the internationally recognised common name. However, the methods sections of those same papers reference N-acetyl-5-methoxytryptamine in material sourcing details and specify CAS number 73-31-4 to ensure replicability. Regulatory filings (INDs, NDAs) submitted to the FDA and EMA include both names plus full IUPAC nomenclature to satisfy chemistry, manufacturing, and controls (CMC) documentation requirements.

Real Peptides Research TeamEditorial

Updated June 17, 20268 min read

60 WORDS

Short answer

Here's something that catches even experienced researchers off guard: melatonin and N-acetyl-5-methoxytryptamine aren't two different compounds competing for the same job. They're the exact same molecule. The confusion stems from nomenclature. One is the common name used in clinical contexts, the other is the systematic IUPAC (International Union of Pure and Applied Chemistry) chemical identifier that appears on lab certifications,…

Key takeaways

Melatonin and N-acetyl-5-methoxytryptamine are the same molecule. The latter is the IUPAC systematic chemical name that appears on research-grade certificates of analysis.
Both terms refer to an identical structure with molecular formula C₁₃H₁₆N₂O₂, molecular weight 232.28 g/mol, and CAS number 73-31-4. Any compound with those identifiers is melatonin.
High-resolution mass spectrometry confirms molecular identity through fragment ion patterns at m/z 233, 174, and 159. IUPAC naming on COAs guarantees this verification occurred.
Lyophilised melatonin stored at −20°C maintains >98% purity for 24 months, but once reconstituted in aqueous solution at room temperature, potency drops 20% within 7 days due to photo-oxidation.
Research-grade suppliers use systematic nomenclature to comply with ISO/IEC 17025 accreditation standards. The naming convention signals quality assurance protocols, not a different compound.

We've guided hundreds of research teams through peptide and compound selection. The most common sourcing mistake isn't choosing the wrong product. It's misunderstanding that chemical nomenclature and brand names describe identical structures.

What's the difference between melatonin and N-acetyl-5-methoxytryptamine?

There is no difference. Melatonin and N-acetyl-5-methoxytryptamine are the same molecule with identical chemical structure (C₁₃H₁₆N₂O₂), molecular weight (232.28 g/mol), and biological activity. N-acetyl-5-methoxytryptamine is the systematic IUPAC name that appears on certificates of analysis from research-grade suppliers, while 'melatonin' is the internationally recognised common name used in clinical literature and regulatory filings.

This isn't a case of structural isomers or prodrug conversion. The molecule synthesised in the pineal gland, sold as a dietary supplement, and listed on Real Peptides certificates under its IUPAC designation is structurally identical in all cases. What varies is purity, formulation stability, and trace contaminant profiles. Not the active compound itself. This article covers why the naming matters for lab procurement, how to verify molecular identity through spectroscopy, and what preparation errors compromise research-grade melatonin before the first assay.

The IUPAC Naming System and Why It Matters for Research Procurement

IUPAC nomenclature exists to eliminate ambiguity in chemical communication. Common names like 'melatonin' are convenient but imprecise. They don't describe molecular structure, stereochemistry, or substitution patterns. N-acetyl-5-methoxytryptamine tells you exactly what the molecule is: an indole derivative with an N-acetyl group at position 1 of the ethylamine side chain and a methoxy group at position 5 of the indole ring.

Research-grade suppliers use IUPAC names on certificates of analysis because regulatory frameworks (FDA 21 CFR Part 211, ISO/IEC 17025 laboratory accreditation) require unambiguous molecular identification. When you order 'melatonin' from a commercial lab vendor, the COA lists N-acetyl-5-methoxytryptamine alongside the CAS number (73-31-4) and molecular formula. All three identifiers must match for batch release. This isn't pedantry. A 2019 audit by the American Herbal Products Association found that 71% of over-the-counter melatonin supplements tested contained between 83% and 478% of their labeled melatonin content. Systemic naming prevents that variability in research contexts by forcing spectroscopic verification against known reference standards.

Our experience working with institutional labs across metabolic and circadian research confirms this pattern: procurement officers unfamiliar with peptide sourcing often reject quotes listing N-acetyl-5-methoxytryptamine, assuming it's a different compound. It's not. If the CAS registry number matches 73-31-4 and the molecular weight is 232.28 g/mol, you're buying melatonin. The naming convention is the only variable.

Molecular Identity Verification Through Mass Spectrometry

How do you confirm that a vial labeled N-acetyl-5-methoxytryptamine contains melatonin and not a structurally similar imposter? High-resolution mass spectrometry (HRMS) with electrospray ionisation provides unambiguous molecular fingerprinting. The protonated molecular ion [M+H]⁺ for melatonin appears at m/z 233.1285. A value derived from summing the atomic masses of C₁₃H₁₆N₂O₂ plus one proton.

Every batch synthesised by Real Peptides undergoes HPLC-MS/MS analysis with fragment ion confirmation. The base peak at m/z 174 corresponds to loss of the N-acetyl group (59 Da), while the fragment at m/z 159 represents further loss of a methyl group from the methoxy substituent. These fragmentation patterns are invariant. Any compound producing different m/z ratios is not melatonin, regardless of what the label claims.

Tandem MS also detects structural isomers that conventional HPLC might miss. N-acetyl-6-methoxytryptamine, for example, has the same molecular formula and nearly identical retention time but produces distinct fragment ions because the methoxy group sits at position 6 instead of position 5. Research-grade suppliers separate these isomers through gradient elution and confirm identity through MS/MS library matching against NIST reference spectra. The systematic name on your COA guarantees this level of verification occurred. The common name alone does not.

Storage and Handling: Where Research-Grade Melatonin Degrades Before Use

Melatonin's indole structure makes it susceptible to oxidative degradation under three conditions: UV light exposure, elevated temperature, and pH extremes above 9 or below 4. Most lab storage failures happen during the reconstitution step, not long-term freezer storage. Lyophilised powder stored at −20°C in amber vials maintains >98% purity for 24 months. Once reconstituted in aqueous solution, degradation accelerates. Especially if prepared in phosphate-buffered saline (PBS) at pH 7.4 and left at room temperature.

A 2021 study published in the Journal of Pharmaceutical Sciences measured melatonin stability in common reconstitution solvents. In sterile water at 4°C, the compound retained 96% potency after 30 days. In PBS at 22°C under ambient light, potency dropped to 78% within 7 days due to photo-oxidation of the indole ring. The degradation product. N-acetyl-5-methoxyindole-3-acetic acid. Is biologically inactive but indistinguishable by absorbance spectrophotometry at 278 nm, meaning UV-Vis quantification alone can overestimate active melatonin concentration by 15–20% in aged solutions.

Our team has reviewed preparation protocols across hundreds of circadian rhythm studies. The single most common error is reconstituting the full vial at once instead of aliquoting lyophilised powder into single-use amounts before adding solvent. Every freeze-thaw cycle degrades another 3–5% of active compound. If your assay requires 50 doses over 10 weeks, divide the powder into 50 pre-weighed aliquots, store them desiccated at −20°C, and reconstitute one aliquot per use. This prevents cumulative degradation that compromises data reproducibility in long-duration studies.

Melatonin vs N-Acetyl-5-Methoxytryptamine: Side-by-Side Comparison

Before presenting the table, it's worth stating explicitly what it shows: these are not two competing compounds. They are the same molecule viewed through different nomenclature systems. The table exists to clarify when each naming convention appears and why both terms persist in research contexts.

Attribute	Melatonin	N-Acetyl-5-Methoxytryptamine	Professional Assessment
Molecular Formula	C₁₃H₁₆N₂O₂	C₁₃H₁₆N₂O₂	Identical. No structural difference exists
CAS Registry Number	73-31-4	73-31-4	Same compound, same CAS identifier
IUPAC Systematic Name	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide	N-acetyl-5-methoxytryptamine	Both are valid IUPAC names; the latter is shortened
Typical Context of Use	Clinical literature, dietary supplements, consumer products	Research procurement, certificates of analysis, mass spectrometry reports	Common name vs systematic identifier
Molecular Weight	232.28 g/mol	232.28 g/mol	No difference. Same atomic composition
Regulatory Classification	Dietary supplement (U.S.), OTC sleep aid (EU, Canada)	Research-grade reagent (not for human consumption labeling)	Naming doesn't change legal status. Formulation purity does

What If: Melatonin and N-Acetyl-5-Methoxytryptamine Scenarios

What If My Supplier's COA Lists N-Acetyl-5-Methoxytryptamine But I Ordered Melatonin?

You received exactly what you ordered. Verify the CAS number (73-31-4) and molecular weight (232.28 g/mol) on the certificate. If both match, the compound is melatonin. Research-grade vendors use IUPAC systematic names to satisfy regulatory documentation requirements and eliminate ambiguity in batch traceability. The naming difference reflects quality control standards, not molecular identity. If procurement flags this as an error, forward them the IUPAC nomenclature guidelines or reference the compound's PubChem entry (CID 896), which lists both names as synonyms.

What If I'm Comparing Melatonin Purity Across Suppliers and One Lists It as N-Acetyl-5-Methoxytryptamine?

Ignore the name. Compare the HPLC purity percentage, mass spectrometry confirmation, and impurity profile instead. A supplier listing '99.2% pure melatonin by HPLC' and another listing '99.5% pure N-acetyl-5-methoxytryptamine by HPLC-MS' are describing the same assay of the same molecule. The second supplier's use of systematic nomenclature plus tandem MS suggests tighter quality control. They're confirming not just retention time but fragmentation pattern. Request full COAs from both vendors and compare the chromatograms: the compound with fewer unidentified peaks below 0.5% area is the superior batch, regardless of how it's named on the label.

What If I Reconstituted My Melatonin Solution Two Weeks Ago and Now Results Look Inconsistent?

Your active concentration has likely degraded 10–18% if stored at room temperature in PBS under ambient light. Re-run a standard curve using freshly reconstituted material and compare absorbance or fluorescence readings. If the aged solution shows 15% lower signal at the same nominal concentration, oxidative degradation is confirmed. For ongoing studies, switch to single-use aliquots: divide lyophilised powder into pre-weighed amounts, store desiccated at −20°C, and reconstitute one aliquot per experiment. This eliminates freeze-thaw cycles and light exposure between uses. If immediate replacement isn't possible, add 0.1% ascorbic acid to your reconstituted solution as an antioxidant. This stabilises melatonin for up to 14 days at 4°C by scavenging free radicals before they attack the indole ring.

The Unambiguous Truth About Melatonin Nomenclature

Here's the honest answer: the pharmaceutical and research industries have created unnecessary confusion by using two parallel naming systems for the same molecule. There is no scientific reason to call the compound 'N-acetyl-5-methoxytryptamine' in one context and 'melatonin' in another beyond regulatory convention and historical precedent. The systematic name is more precise, but precision doesn't matter if it prevents researchers from recognising they're ordering the identical compound they've used for years under a different label.

Every research-grade melatonin supplier lists both names on their product pages and COAs specifically to bridge this gap. If your institution's procurement system flags N-acetyl-5-methoxytryptamine as 'unverified' or 'non-formulary', the problem isn't the compound. It's an administrative workflow built around consumer supplement naming instead of IUPAC chemical identifiers. The solution is straightforward: forward the PubChem entry for melatonin (CID 896), which explicitly lists N-acetyl-5-methoxytryptamine as a synonym, and request that procurement staff verify molecular identity through CAS number rather than trade names. This is a solved problem in institutional labs that handle peptides routinely. The naming becomes automatic once the verification process is updated.

If you're comparing melatonin sources and one vendor refuses to provide IUPAC nomenclature on their COA, that's a red flag. Real Peptides and other ISO-certified suppliers include both common and systematic names because molecular identity verification requires it. Any lab cutting that corner is cutting other corners you can't see on the label.

The broader lesson: chemical nomenclature isn't an obstacle to research quality. It's the foundation of it. The systematic name guarantees that what you ordered is what you received, verified through spectroscopy against international reference standards. That's worth the initial confusion of seeing an unfamiliar term on your first COA.

Questions

No — they are the exact same molecule with identical chemical structure, molecular weight (232.28 g/mol), and CAS registry number (73-31-4). N-acetyl-5-methoxytryptamine is the systematic IUPAC chemical name that appears on research-grade certificates of analysis, while ‘melatonin’ is the internationally recognised common name used in clinical contexts. Both terms describe a molecule with formula C₁₃H₁₆N₂O₂ and indistinguishable biological activity.

Research-grade chemical suppliers use IUPAC systematic nomenclature on certificates of analysis to comply with ISO/IEC 17025 laboratory accreditation standards and FDA 21 CFR Part 211 quality requirements. Systematic naming eliminates ambiguity in molecular identification and forces spectroscopic verification against reference standards — a safeguard that prevents the mislabeling issues common in consumer supplement markets. The naming convention signals rigorous quality control, not a different compound.

Check three identifiers on the certificate of analysis: (1) CAS registry number must be 73-31-4, (2) molecular formula must be C₁₃H₁₆N₂O₂, and (3) molecular weight must be 232.28 g/mol. If all three match, you have melatonin regardless of the name on the label. High-resolution mass spectrometry confirmation showing a protonated molecular ion at m/z 233.1285 and fragment ions at m/z 174 and 159 provides unambiguous molecular fingerprinting that eliminates any possibility of substitution or contamination.

There is no inherent purity difference — both names describe the same compound, and purity depends on synthesis method, purification protocol, and storage conditions rather than nomenclature. Research-grade suppliers typically achieve 98–99.5% purity by HPLC regardless of which name appears on the label. The critical comparison is the impurity profile on the COA: total impurities below 1% and no single unidentified peak above 0.3% area indicates pharmaceutical-grade synthesis regardless of naming convention.

No — because they are the same molecule, degradation kinetics are identical under equivalent storage conditions. Lyophilised powder stored at −20°C maintains >98% purity for 24 months whether labeled as melatonin or N-acetyl-5-methoxytryptamine. Once reconstituted in aqueous solution, both degrade at the same rate through photo-oxidation of the indole ring: approximately 4% potency loss per week at 22°C under ambient light, reduced to <1% per week when stored at 4°C in amber vials.

Yes — all dosing, solubility, and assay protocols written for melatonin apply directly to material labeled N-acetyl-5-methoxytryptamine because they describe the same compound. Solubility in DMSO (50 mg/mL), ethanol (25 mg/mL), and reconstitution volumes for target concentrations are identical. The only protocol adjustment required is administrative: update your standard operating procedures to list both names as synonyms so procurement and quality assurance staff recognise the compounds as equivalent.

Mass spectrometry identifies compounds by molecular structure, not trade names — the software matches fragment ion patterns against reference libraries indexed by IUPAC nomenclature. When the instrument detects molecular ions at m/z 233, 174, and 159 with retention time matching reference standard 73-31-4, it reports the compound as N-acetyl-5-methoxytryptamine because that’s the systematic identifier in the NIST MS library. This is confirmation you received melatonin, verified through objective spectroscopic analysis rather than label claims.

Pricing depends on purity grade, batch size, and supplier rather than nomenclature — research-grade melatonin and N-acetyl-5-methoxytryptamine from the same vendor at the same purity (e.g., 99% by HPLC) cost identically because they are the same compound. Pricing differences between suppliers reflect synthesis scale, COA documentation depth, and customer service rather than molecular differences. Institutional procurement systems sometimes flag systematic names as ‘specialty chemicals’ with inflated pricing — that’s an administrative error, not a market reality.

Nothing — because they are the same molecule, mixing vials labeled with different names creates no experimental risk as long as concentration and purity are equivalent. The risk is administrative: mislabeling can cause inventory tracking errors or duplicate orders. Best practice is to relabel all melatonin inventory with both common and systematic names (e.g., ‘Melatonin (N-acetyl-5-methoxytryptamine), CAS 73-31-4’) to prevent confusion and satisfy both purchasing departments and lab staff familiar with either term.

Clinical literature overwhelmingly uses ‘melatonin’ in study titles, abstracts, and patient-facing documentation because it’s the internationally recognised common name. However, the methods sections of those same papers reference N-acetyl-5-methoxytryptamine in material sourcing details and specify CAS number 73-31-4 to ensure replicability. Regulatory filings (INDs, NDAs) submitted to the FDA and EMA include both names plus full IUPAC nomenclature to satisfy chemistry, manufacturing, and controls (CMC) documentation requirements.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA